The development and emergence of incretin-based multi-agonists on the market for T2DM and obesity treatment are quite encouraging
Yang Y, Cui X, Chen Y, Wang Y, Li X, Lin L et al (2014) Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity
doi: 10.1007/s11154-023-09805-5 32 van BaakMAPramonoABattistaFBeaulieuKBlundellJEBusettoLet al
The transition bumps
Data curation: Karen Feghali
49,66 Metabolic benefits of GLP-1RA in the management of weight-related MASLD MASLD is highly correlated with other metabolic disorders and may even be a mutual cause, compounded by a wide range of disease development stages, making its management highly complex